| Scientific News - CNIO - page 26
Let

Home | News | Scientific News | Page 26

Scientific News

Basic Research
 20.11.2014 Cancer Cell. A CNIO team discovers that a derivative of vitamin B3 prevents liver cancer in mice Study published today in the journal ‘Cancer Cell’ Translational
 14.11.2014 European Urology. International study concludes conventional therapies are less efficient in prostate cancer patients carrying ‘BRCA’ mutations Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to... CNIO scientist challenge the efficacy of FOLFIRI in a colorectal cancer subtype under question Translational
 06.11.2014 Nature Medicine. CNIO scientist challenge the efficacy of FOLFIRI in a colorectal cancer subtype under question The current classification system for colorectal cancer, which is based on genetic expression... Basic Research
 05.11.2014 PNAS. CNIO researchers create a mouse model that reproduces Noonan syndrome Noonan syndrome is a rare disease that is characterised by a set of pathologies, including heart,... CNO researchers associate two oncogenes are associated with the agressiveness and incidence of leukaemia in mice Basic Research
 10.10.2014 Blood. CNO researchers associate two oncogenes are associated with the agressiveness and incidence of leukaemia in mice Proteins regulating cell division determine tumour growth. Ongoing clinical trials are currently... A molecular mechanism involved in cellular proliferation characterised Basic Research
 29.09.2014 Nature Communications. A molecular mechanism involved in cellular proliferation characterised Researchers from Guillermo Montoya’s team at the Spanish National Cancer Research Centre (CNIO),... Basic Research
 28.09.2014 Nature Methods. Experts from CNIO discover shining cells responsible for developing tumours Tumours are mosaics of cells that are morphologically and molecularly very different. In this... CNIO successfully completes its first clinical trial on HER-2-Negative breast cancer with Nintedanib Translational
 09.09.2014 British Journal of Cancer. CNIO successfully completes its first clinical trial on HER-2-Negative breast cancer with Nintedanib The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a... Basic Research
 03.09.2014 Nature Communications. CNIO experts discover the genomic origin of telomere protectors RNA is one of the most primitive molecules associated with life that has awakened most interest over...
1 … 24 25 26 27 28 … 31

Up